Cytoplasmic liver kinase B1 promotes the growth of human lung adenocarcinoma by enhancing autophagy

Mengjie Liu, Lili Jiang, Xiao Fu, Wenjuan Wang, Jiequn Ma, Tao Tian, Kejun Nan, Xuan Liang

Cancer Science · 2018 · 45 citations · 10 references

DOIFull text

Open access

Concepts

Abstract

Liver kinase B1 ( LKB 1 ) as a tumor suppression gene that is associated with various kinds of cancers, including lung cancer. In this study, we found that the effect of LKB 1 on tumor growth was dependent on its subcellular expression in A549 and HCC 827 cells. Full‐length LKB 1 decreased the proliferation and clonogenicity of A549‐ LKB 1 and HCC 827‐ LKB 1 cells, but increased their apoptosis. Opposite effects were observed in A549‐ LKB 1 s and HCC 827‐ LKB 1 S cells that overexpressed truncated LKB 1 without the nuclear localization sequence. The truncated cytoplasmic LKB 1 enhanced the growth of implanted tumors in vivo. The truncated cytoplasmic LKB 1 promoted autophagy, which was independent of AMP ‐activated protein kinase and mTOR signaling in A549 and HCC 827 cells. Further characterization indicated that higher levels of cytoplasmic LKB 1 expression were associated with advanced TNM stage and reduced overall survival (OS) in 190 patients with adenocarcinoma. In contrast, high nuclear expression of LKB 1 is associated with early TNM stage and longer OS . The high level of cytoplasmic LKB 1 expression was an independent risk factor for poor overall survival in patients with adenocarcinoma. Together, our results revealed that cytoplasmic LKB 1 promotes the growth of lung adenocarcinoma and could be a prognostic marker for lung adenocarcinoma.

References

10